The trademark application Arcalyst was filed by Regeneron Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on April 15, 2020, and it was registered by office on July 23, 2020 without any oppositions.
The application was filed in English (Spanish was selected as the second language).